Rhizavidin variants

Abstract

The present disclosure provides technologies (e.g., compositions, methods, and kits, etc.) for rhizavidin variants. In particular, the disclosure provides a variant rhizavidin polypeptide, comprising a mutation at one or more N-linked glycosylation sites of a wild-type rhizavidin polypeptide, fusion proteins comprising the variant rhizavidin polypeptide, compositions comprising the variant rhizavidin polypeptide or fusion protein and uses in immunization or methods of immunization.

Dependencies are inferred from the claim text.